driving innovation to market.
News Bulletin - May, 2013  
UCLA INVENTS is a monthly bulletin published by the Office of Intellectual Property (OIP) to highlight entrepreneurship, innovation, and technology commercialization at UCLA. [ subscribe ]
Faculty and Industry Execs Network at 1st Annual Medical Device Partnering Conf.
UCLA Med Device Event Logo
Event Hosted by OIP to help foster new collaborations and showcase UCLA technology commercialization successes.

Breakthrough medical devices have been part of UCLA’s history for many decades. The nicotine patch first commercialized in 1992, the Guglielmi Detachable Coil (GDC®) for treating life-threatening aneurysms, and an intravascular clot retriever for stroke intervention are just a few examples of commercially successful, life-changing medical devices that have roots on our Westwood campus.

It is evident from these and other UCLA products that partnership with industry is a critical component of successful technology transfer. Furthermore, these medical device successes underscore the rich source of innovation that the research community at UCLA has been and continues to be...

Read Full Article 
View Event Program (Agenda, Speaker bios; Technologies; pdf]


BioTime Enters into License Agreement with UCLA to Develop Stroke Therapy
BioTime Inc Logo
Sponsored Research also to support on-going pre-clinical work in Dr. Tom Carmichael's lab.

BioTime, Inc. announced on April 19, 2013 that it has entered into an exclusive license agreement with the University of California, Los Angeles (UCLA) for novel technology related to the treatment of stroke. The licensed technology, developed in the laboratories of Tom Carmichael, MD, PhD of UCLA’s Department of Neurology, at the David Geffen School of Medicine, uses one of BioTime’s HyStem® hydrogels to deliver locally released growth factors to improve recovery from stroke. Pre-clinical studies have demonstrated that the localized delivery of growth factors such as brain-derived neurotrophic factor (BDNF) results in a statistically significant improvement in post-stroke motor function in a murine model of ischemic stroke.

[ Read Full Press Release ]
[ BioTime Inc. ]


STARTUP 101 Seminar Series Announced for Faculty, Staff & Student Entrepreneurs
UCLA Class
OIP Entrepreneurs-in-Residence will conduct a series of 4 lectures for
UCLA entrepreneurs.

Sandra Itkoff and John Gillespie, Entrepreneurs-in-Residence with the UCLA Office of Intellectual Property, will conduct a series of four lectures for faculty, staff and students on how to create a successful startup business.

Topics to be covered include market definition, business plan development, legal organization, financial modeling, fundraising/investor presentations, marketing strategy, management team recruiting, corporate governance, managing conflicts of interest and the path to liquidity. Lectures will include case studies (some with quest speakers) and conclude with an opportunity for participants to ask questions."

The first session, "Identifying the Opportunity," is scheduled for May 13, 2013 at CNSI.

More Information and Registration ]


    TechTransfer 'Roundup:  UCLA Startup Funding and IP Licensing Developments
    Highlighting selected startup funding and IP licensing announcements featured in previous issues of UCLA Invents.

    • ArmaGen Technologies Announces $17 Million Series A Financing [ more]
    • C3 Jian Closes $30 Million Financing [more]
    • UCLA Startup, Tribogenics, Raises $6.2 Million Series A Round Led by Peter Thiel's Founders Fund [more]
    • UCLA Licensee, NeuroSigma, Announces Issued Patent on eTNS Technology for the Treatment of Neuropsychiatric Disorders [ more]
    • UCLA Licensee, Kythera Biopharmaceuticals, Inc., Announces Closing of IPO  [more]
    • UCLA Licensee, ImmunGene, Forms Joint Venture to Develop Antibody-Interferon Fusion Therapeutics to Treat Cancer [more]
    • Islet Sciences Announces Exclusive License with UCLA to Commercialize Small Molecules for Islet Expansion [more]


      New Technologies Discovered by UCLA Inventors Available for Licensing
      Kinross Bldg
      UCLA technology is commercialized by entrepreneurs and established companies - locally and worldwide.

      Novel Application of Laser Lithotripsy for Treating Peripheral Arterial Disease
      UCLA researchers in the Division of Interventional Radiology have developed an improved laser lithotripsy technology for the treatment of peripheral arterial disease under direct visualization.

      Magnetic Resonance Microcoil Useful In Research, Diagnosis And Disease Treatment
      UCLA investigators have developed a magnetic resonance microcoil with a high signal-to-noise ratio allowing for microscopic imaging and spectroscopy. The device can be implantable in patients and also used in a variety of fields including research, diagnosis, and disease treatment.

      A Novel Immuno-PET Tracer for Imaging of CD20
      UCLA researchers have developed the first humanized, non-internalizing tracers for immunological positron emission tomography (PET) imaging.

      RadPath: An Integrated Radiology And Pathology Report
      UCLA researchers in the Department of Radiology and the Department of Pathology & Laboratory Medicine have developed a novel web application that integrates radiology and pathology reports into a diagnostic consultation.

      Detection of Compounds with Mutagenic and Carcinogenic Potential
      CLA researchers at the California NanoSystems Institute (CNSI) and the Department of Medicine have developed an in vitro biological assay using human cell lines to detect carcinogenic and mutagenic properties of chemical compounds.

      NMR Probe for the Detection of Microstructures
      UCLA researchers in the Department of Chemistry and Biochemistry have developed an NMR probe with superior sensitivity for in vivo spectroscopy and detection of ultra small samples.

      Chemical Sintering For High Throughput Generation Of Porous Scaffolds
      UCLA researchers in the Chemical and Biomolecular Engineering department have developed a chemical sintering method for the enhanced production of porous scaffolds for tissue-engineering applications.



      @ OIP

      Date: May 03, 2013 
      Time: 9am-10:30am
      Place: Kinross Bldg., Suite 210

      Guest Speaker:
      Robert Jadon, 
      Director Startup UCLA Accelerator

      "Startup UCLA Accelerator Program - Overview and Latest Developments."

      [ RSVP ]

      Building a Foundation in Research at UCLA

      Date: May 10, 2013
      Time: 9:30am - 2:30pm
      Place: CNSI @ UCLA

      The half-day workshop will provide UCLA faculty, research staff, and graduate students with an overview of the many resources available to the UCLA research community.

      UCLA participating organizations include: CTSI, CFRR, OVCR, SoM, BioMedical Library, and OIP-ISR.

      [ Info & Registration  ]


      June 12, 2013
      9:00am - 7:pm
      Place: ROC, Santa Monica

      First Look L.A. supports, nurtures and stimulates our unique culture in Southern California, while furthering L.A.s position as a center for start-ups and emerging technology.

      In addition to the presenters, venture capitalists and early stage angel investors attend the event, along with local elected officials, business leaders and senior administrators from the universities.

         [ Info & Registration ]

      Patent Image
      UCLA patents recently issued by the USPTO:

      8,421,035  High-resolution microscope using optical amplification | Jia-Ming Liu, et al.

      8,416,033  Compact dual-band metamaterial-based hybrid ring coupler | Tatsuo Itoh, et al.

      8,415,089  Single-mask double-patterning lithography | Puneet Gupta, et al.

      8,405,470  Diplexer synthesis using composite right/left-handed phase-advance/delay lines | Tatsuo Itoh, et al.

      8,405,469  Composite right/left (CRLH) couplers | Tatsuo Itoh, et al.

      8,404,635  Orally administered peptides synergize statin activity | Alan M. Fogelman, et al.

      8,399,057  Ordered vertically oriented porous inorganic films produced through solution processing | Sarah H. Tolbert, et al.

      8,396,181  Method and apparatus for generating nuclear fusion using crystalline materials | Seth Putterman, et al.

      8,389,679  Targeted antimicrobial moieties | Wenyuan Shi, et al.


      Previous issues of
      the UCLA Invents
      news bulletin are
      available online


       UCLA INVENTS Vol. 1, No. 9

      The UCLA INVENTS News Bulletin is published by UCLA's Office of Intellectual Property and Industry Sponsored Research (OIP-ISR). UCLA INVENTS highlights entrepreneurial and technology commercialization developments, and opportunities at UCLA.

      PLEASE ATTENTION editorial comments, corrections, and topic suggestions to:  
      Bob Nidever,   bnidever@research.ucla.edu

        Bob Nidever

        Erin Bowers
        Neil Bajpayee

        Sarah Honig

      To subscribe, please visit:   UCLAinvents.com   

      UCLA Office of Intellectual Property and Industry Sponsored Research

      11000 Kinross Ave., Suite 200; Los Angeles, CA 90095 | tel. 310-794-0558 |  http://oip.ucla.edu

      Copyright 2013 UC Regents

      Share this